Cecilia Monge, M.D., M.P.H., FACP
- Center for Cancer Research
- National Cancer Institute
- Building 10, Room 8D44E
- Bethesda, MD 20892
- 240-858-3603
- cecilia.mongebonilla@nih.gov
RESEARCH SUMMARY
Dr. Cecilia Monge specializes in first-in-human and early-phase clinical studies of gastrointestinal (GI) malignancies, including liver cancer, biliary tract cancer and colorectal cancer. Her research interests also include Cancer Health Disparities.
Areas of Expertise
Information for Patients
Learn more about our clinical trials and the highly specialized care teams that lead them.
Cecilia Monge, M.D., M.P.H., FACP
Clinical Trials
Research
Dr. Cecilia Monge is involved in clinical research focusing on novel first-in-human and early-phase clinical trials within the realm of gastrointestinal (GI) tumors and immunology. Her research interests also include Healthcare Disparities. She has served as chair and investigator of multiple early stage clinical study protocols within the National Cancer Institute, National Institutes of Health. Dr. Monge is part of National Institutes of Health Institutional Review Board (IRB) and the National Cancer Institute Safety Review Committee.
Publications
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
Biography
Cecilia Monge, M.D., M.P.H., FACP
Dr. Cecilia Monge joined the Thoracic and GI Malignancies Branch as Staff Oncology Physician in 2019 after finishing her oncology fellowship with an outstanding academic award at the National Institutes of Health (NIH). She holds a Masters degree in public health from the Johns Hopkins University, Bloomberg School of Public Health and was selected to participate in the Global Clinical Scholars Research Training Program at Harvard Medical School. Dr. Monge completed her internal medicine training at Georgetown University after graduating from the Universidad de Costa Rica Medical School.
Dr. Cecilia Monge is the recipient of multiple national and international academic and research awards in oncology and internal medicine. She serves as a reviewer for various oncology academic journals and is a member of the American Academy of Cardiology (ACC) Cardio-Oncology Guidelines Writing Committee and the American Society of Clinical Oncology (ASCO) Trainee Council. Dr. Monge also serves on the NIH National Cancer Institute Institutional Scientific Review Board (IRB) for Clinical Studies, NCI Safety Committee, and she is a fellow of the American College of Physicians. She is board certified in Internal Medicine and Medical Oncology.